Targeting myeloid-derived suppressor cells (MDSCs) with immune checkpoint inhibitors for treating cisplatin-resistant bladder cancer

Targeting myeloid-derived suppressor cells (MDSCs) with immune checkpoint inhibitors for treating cisplatin-resistant bladder cancer

Bibliographic Details
Main Authors: Y. Takeyama, M. Kato, S. Tamada, Y. Azuma, Y. Shimizu, T. Iguchi, T. Yamasaki, M. Gi, H. Wanibuchi, T. Nakatani
Format: Article
Language:English
Published: Elsevier 2020-07-01
Series:European Urology Open Science
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168320326124

Internet

http://www.sciencedirect.com/science/article/pii/S2666168320326124

Similar Items